Initial public offering of Bioretec


Danske Bank is acting as the Global Coordinator in Bioretec Ltd’s (”Bioretec”) initial public offering and listing of shares on Nasdaq First North Growth Market Finland. 

Below is an overview of key dates in connection with the initial public offering and listing of shares as well as links to prospectus, marketing brochure, web subscription and eBanking services (only for Danske Bank’s customers).

Key dates

  • Prospectus available at latest 7 June 2021
  • Subscription period for the offering begins 7 June 2021 at 10:00 a.m.
  • Offering may be discontinued no earlier than 14 June 2021 at 4:00 p.m.
  • Subscription period for the public offering ends 15 June 2021 at 4:00 p.m.
  • Subscription period for the institutional offering ends 17 June 2021 at 4:00 p.m.
  • The final subscription price and results of the offering will be announced 17 June 2021 (estimate)
  • New shares allocated in the public offering recorded in the investors’ book-entry accounts on 18 June 2021 (estimate)
  • First day of trading on the Nasdaq Helsinki First North Growth Market 18 June 2021 (estimate)
  • The Offer Shares allocated in the Institutional Offering will be ready to be delivered against payment through Euroclear Finland 22 June 2021 (estimate)

    Bioretec in brief

    Bioretec is a medical device company focusing on the development and manufacturing of strong and safe bioresorbable implants for the treatment of bone and soft tissue injuries.

    The advantage of Bioretec's implants compared to traditional metal implants is that bioresorbable implants eliminate the need for implant removal operations that result in costs and may involve complications.

    General terms and conditions of web subscription and investor announcement

    Verkkomerkinnän yleiset ehdot

    Sijoittajatiedote

    IPO material as well as Bioretec investor website

    Prospectus

    Marketing brochure (in Finnish)